FEB 13, 2017 1:54 PM PST

Females More Prone to Disease Due to Key Immunological Difference

WRITTEN BY: Kara Marker

There seems to be a key genetic difference between males and females that is not related to sex chromosomes. Instead, it is a difference in activity between the two sexes in a specific type of immune cell which leaves females more vulnerable to some stress-related and allergic diseases.

The immune cell found in this study to put females at an increased risk for certain diseases is the mast cell. These immune components usually do not circulate in the bloodstream the way other immune cells do. Instead, they exist in tissue types all over the body fulfilling a plethora of roles such as vasodilation, angiogenesis, pathogen elimination, and even maintenance of other immune cells.

From Michigan State University, in a new study published in the journal Biology of Sex Differences, researchers picked apart and examined several genes within the RNA genome. "Over 8,000 differentially expressed genes were found in female mast cells compared to male mast cells," said lead researcher and associate professor Adam Moeser said. "While male and female mast cells have the same sets of genes on their chromosomes, with the exception of the XY sex chromosomes, the way the genes act vary immensely between the sexes."

Specifically, they saw an increase in inflammatory activity linked to mast cells in females that causes a more intense immune response to stress and allergy, resulting in diseases like irritable bowel syndrome (IBS). Doctors aren’t sure what causes IBS, but the associated symptoms seem to be consistent: abdominal pain and discomfort, changes in bowel movements, and bloating.

With this research completed, transitioning to sex-specific treatments that directly target mast cells in females specifically is definitely something that will be considered. The next question Moeser and his team will have to answer though is this: at what point to mast cells begin to act differently between males and females?

“Pinpointing when this variance happens will let us know if it occurs during adulthood or in individuals at an early age," Moeser said. "Many mast cell diseases exhibit a sex bias in children and if we can identify the timing and the mechanism of what's influencing the change, we'll have an even better understanding of how these immune cells cause disease and know when to intervene with potentially new therapies."

Sources: Michigan State University, Frontiers in Immunology, National Institute of Diabetes and Digestive and Kidney Diseases

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
APR 21, 2020
Immunology
Sino Biological Focuses on Serological Studies of COVID-19
APR 21, 2020
Sino Biological Focuses on Serological Studies of COVID-19
April 17, 2020, Sino Biological announced this week that the company launched the world’s first coronavirus antige ...
JUN 14, 2020
Microbiology
Amping Up Immunity to Respiratory Viruses by Targeting Memory T Cells in the Lungs
JUN 14, 2020
Amping Up Immunity to Respiratory Viruses by Targeting Memory T Cells in the Lungs
It's easier than thought to activate immune cells that reside in the lungs and are involved in long-term immunity. Image ...
JUN 23, 2020
Immunology
Nanosponges Mop up Viruses to Treat COVID Infections
JUN 23, 2020
Nanosponges Mop up Viruses to Treat COVID Infections
  Scientists have developed an experimental therapy for COVID-19 that uses coated nanoparticles to intercept SARS-C ...
JUL 07, 2020
Immunology
Existing drugs can prevent SARS-CoV-2 from hijacking cells
JUL 07, 2020
Existing drugs can prevent SARS-CoV-2 from hijacking cells
An international team of researchers has analysed how SARS-CoV-2, the virus that causes COVID-19, hijacks the proteins i ...
JUL 09, 2020
Immunology
Why COVID Herd Immunity Is Important but Impossible
JUL 09, 2020
Why COVID Herd Immunity Is Important but Impossible
The number of confirmed COVID-19 cases worldwide is steadily approaching 12 million. Meanwhile, despite accelerated time ...
JUL 08, 2020
Immunology
Scientists Use Genetics to Control Regulatory T Cells
JUL 08, 2020
Scientists Use Genetics to Control Regulatory T Cells
The ability to control regulatory T cells of the immune system has long been sought out by scientists, especially those ...
Loading Comments...